WO2022040644A3 - Compositions d'acide bêta-hydroxybutyrique et procédés d'administration orale de corps cétoniques - Google Patents
Compositions d'acide bêta-hydroxybutyrique et procédés d'administration orale de corps cétoniques Download PDFInfo
- Publication number
- WO2022040644A3 WO2022040644A3 PCT/US2021/050302 US2021050302W WO2022040644A3 WO 2022040644 A3 WO2022040644 A3 WO 2022040644A3 US 2021050302 W US2021050302 W US 2021050302W WO 2022040644 A3 WO2022040644 A3 WO 2022040644A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- beta
- hydroxybutyric acid
- oral delivery
- gels
- suspensions
- Prior art date
Links
- WHBMMWSBFZVSSR-UHFFFAOYSA-N 3-hydroxybutyric acid Chemical compound CC(O)CC(O)=O WHBMMWSBFZVSSR-UHFFFAOYSA-N 0.000 title abstract 14
- 150000002576 ketones Chemical class 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000002378 acidificating effect Effects 0.000 abstract 3
- 239000000499 gel Substances 0.000 abstract 3
- 239000000725 suspension Substances 0.000 abstract 3
- 230000002496 gastric effect Effects 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- WHBMMWSBFZVSSR-GSVOUGTGSA-N (R)-3-hydroxybutyric acid Chemical compound C[C@@H](O)CC(O)=O WHBMMWSBFZVSSR-GSVOUGTGSA-N 0.000 abstract 1
- 208000010444 Acidosis Diseases 0.000 abstract 1
- 239000003513 alkali Substances 0.000 abstract 1
- 229910001413 alkali metal ion Inorganic materials 0.000 abstract 1
- 229910001420 alkaline earth metal ion Inorganic materials 0.000 abstract 1
- 239000008280 blood Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 abstract 1
- 239000006172 buffering agent Substances 0.000 abstract 1
- 230000009429 distress Effects 0.000 abstract 1
- 239000003792 electrolyte Substances 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Cosmetics (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2021327408A AU2021327408A1 (en) | 2020-08-18 | 2021-09-14 | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
JP2023512075A JP2023541360A (ja) | 2021-03-24 | 2021-09-14 | ベータ-ヒドロキシ酪酸組成物およびケトン体の経口送達方法 |
CA3192343A CA3192343A1 (fr) | 2020-08-18 | 2021-09-14 | Compositions d'acide beta-hydroxybutyrique et procedes d'administration orale de corps cetoniques |
CN202180070607.5A CN116940352A (zh) | 2021-03-24 | 2021-09-14 | 用于经口递送酮体的β-羟基丁酸组合物和方法 |
MX2023001899A MX2023001899A (es) | 2021-03-24 | 2021-09-14 | Composiciones de acido beta-hidroxibutirico y metodos para suministro oral de cuerpos de cetona. |
EP21859286.3A EP4200274A2 (fr) | 2020-08-18 | 2021-09-14 | Compositions d'acide bêta-hydroxybutyrique et procédés d'administration orale de corps cétoniques |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/996,509 US10973786B2 (en) | 2016-03-11 | 2020-08-18 | R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions |
US16/996,509 | 2020-08-18 | ||
US17/210,646 US11806324B2 (en) | 2018-04-18 | 2021-03-24 | Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies |
US17/210,646 | 2021-03-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2022040644A2 WO2022040644A2 (fr) | 2022-02-24 |
WO2022040644A3 true WO2022040644A3 (fr) | 2022-04-07 |
Family
ID=80323202
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2021/050302 WO2022040644A2 (fr) | 2020-08-18 | 2021-09-14 | Compositions d'acide bêta-hydroxybutyrique et procédés d'administration orale de corps cétoniques |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP4200274A2 (fr) |
AU (1) | AU2021327408A1 (fr) |
WO (1) | WO2022040644A2 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11026929B2 (en) | 2016-04-19 | 2021-06-08 | Keto Patent Group, Inc. | Administration of berberine metabolites |
US20230346699A1 (en) * | 2022-04-28 | 2023-11-02 | Axcess Global Sciences, Llc | Administration of r-beta-hydroxybutyrate and related compounds in veterinary applications |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110287114A1 (en) * | 2010-05-24 | 2011-11-24 | Amerilab Technologies, Inc. | Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition |
WO2018187324A1 (fr) * | 2017-04-04 | 2018-10-11 | NNB Nutrition USA, LLC | Préparation de l'acide (r)-3-hydroxybutyrique ou ses sels par fermentation en une étape |
US20190177673A1 (en) * | 2017-08-23 | 2019-06-13 | KetoneAid Inc. | Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol |
WO2019204148A1 (fr) * | 2018-04-18 | 2019-10-24 | Access Global Sciences, Llc | Compositions et procédés pour l'empilement céto avec du bêta-hydroxybutyrate et de l'acétoacétate |
-
2021
- 2021-09-14 WO PCT/US2021/050302 patent/WO2022040644A2/fr active Application Filing
- 2021-09-14 AU AU2021327408A patent/AU2021327408A1/en active Pending
- 2021-09-14 EP EP21859286.3A patent/EP4200274A2/fr active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20110287114A1 (en) * | 2010-05-24 | 2011-11-24 | Amerilab Technologies, Inc. | Effervescent composition for forming a gelled composition, tablet for forming a gelled composition, and method of making a gelled composition |
WO2018187324A1 (fr) * | 2017-04-04 | 2018-10-11 | NNB Nutrition USA, LLC | Préparation de l'acide (r)-3-hydroxybutyrique ou ses sels par fermentation en une étape |
US20190177673A1 (en) * | 2017-08-23 | 2019-06-13 | KetoneAid Inc. | Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol |
WO2019204148A1 (fr) * | 2018-04-18 | 2019-10-24 | Access Global Sciences, Llc | Compositions et procédés pour l'empilement céto avec du bêta-hydroxybutyrate et de l'acétoacétate |
Also Published As
Publication number | Publication date |
---|---|
EP4200274A2 (fr) | 2023-06-28 |
AU2021327408A1 (en) | 2023-04-20 |
WO2022040644A2 (fr) | 2022-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022040644A3 (fr) | Compositions d'acide bêta-hydroxybutyrique et procédés d'administration orale de corps cétoniques | |
JP2019073540A5 (fr) | ||
RU2009146297A (ru) | Дезинфекционное средство на основе водных растворов, которые содержат хлорноватистую кислоту (hocl), способ его получения и применение | |
JP5757975B2 (ja) | 二酸化塩素用の安定化組成物 | |
US8951576B2 (en) | Process for producing aqueous chlorous acid solution for use as disinfectant | |
CA2555136A1 (fr) | Compositions d'absorption d'oxygene et procede correspondant | |
RU2011152950A (ru) | Композиция зубной пасты | |
RU2007122365A (ru) | Содержащая цинк оральная композиция с улучшенным вкусом | |
WO2008111357A1 (fr) | Solution pure de dioxyde de chlore, et composition de type gel et composition moussante comprenant chacune cette solution | |
EP2554050A4 (fr) | Agent à base de chlore combiné, et son procédé de fabrication et son procédé d'utilisation | |
RU2015123446A (ru) | Стабильные композиции, содержащие ион металла | |
RU2012150279A (ru) | Гранулы фермента | |
NZ599377A (en) | Salts, aqueous liquid compositions containing salts of S-(+)-abscisic acid and methods of their preparation | |
BR112014015935A2 (pt) | composição de agentes de detecção de células tumorais epiteliais e seu método de preparação | |
RU2015121111A (ru) | Композиция по уходу за полостью рта | |
MX2023001899A (es) | Composiciones de acido beta-hidroxibutirico y metodos para suministro oral de cuerpos de cetona. | |
AU2003289928A1 (en) | Coated peroxygen compounds with controlled release, a process for their preparation and their use | |
JP2011026350A5 (fr) | ||
CN108169431A (zh) | 一种人工唾液及其制备方法 | |
PT86506B (pt) | Metodo de preparacao de produtos para higiene de boca contendo uma oxido-redutase | |
RU2008111067A (ru) | Стабилизированные и консервированные глазные композиции, содержащие кетотифен | |
JP2014073451A5 (fr) | ||
TR201006273T1 (tr) | Fotosentezi hızlandıracak bir ürün. | |
GB1209319A (en) | Improved toothpaste | |
JP5046077B2 (ja) | S−アデノシルメチオニンの安定化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21859286 Country of ref document: EP Kind code of ref document: A2 |
|
ENP | Entry into the national phase |
Ref document number: 2023512075 Country of ref document: JP Kind code of ref document: A Ref document number: 3192343 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021859286 Country of ref document: EP Effective date: 20230320 |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21859286 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202180070607.5 Country of ref document: CN |
|
ENP | Entry into the national phase |
Ref document number: 2021327408 Country of ref document: AU Date of ref document: 20210914 Kind code of ref document: A |